Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02584309
Title Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field